Literature DB >> 20156100

Genetic characterization of HIV type 1 Nef-induced vesicle secretion.

Syed A Ali1, Ming-Bo Huang, Patrick E Campbell, William W Roth, Tamika Campbell, Mahfuz Khan, Gale Newman, Francois Villinger, Michael D Powell, Vincent C Bond.   

Abstract

The HIV-1 Nef protein is known to be secreted, and our group has shown that Nef is secreted from nef-transfected and HIV-1-infected cells in small exosome-like vesicles (d. 40-100 nm). The role of secreted Nef remains to be fully characterized. Thus, it is important to characterize the nature of and the mechanisms regulating Nef secretion. We hypothesized that specific structural domains on the Nef protein interact with components of the endosomal trafficking machinery, sorting Nef into multivesicular bodies (MVB) and packaging it in exosome-like vesicles. To identify those domains, a series of mutants spanning the entire nef sequence were made and cloned into the expression vector pQB1, which expresses the mutants as Nef-GFP fusion proteins. These constructs were used in transient transfection assays to identify sequences necessary for secretion of the Nef-GFP fusion protein. N-terminal domains were identified as critical for Nef-induced vesicle secretion: (1) a basic cluster of four arginine residues (aa 17, 19, 21, 22), (2) the phosphofurin acidic cluster sequence (PACS; Glu62-65), and (3) a previously uncharacterized domain spanning amino acid residues 66-70 (VGFPV), which we named the secretion modification region (SMR). Additional amino acids P25, 29GVG31, and T44 were identified in HIV-1 Nef as regulating its secretion. These residues have not been associated with other reported Nef functions. The myristoylation domain, ubiquitination lysine residues, and the C-terminal portion of Nef (aa 71-206) had no effect on secretion. A minimal HIV-1 Nef sequence, comprising the identified motifs, was sufficient for Nef-induced vesicle secretion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156100      PMCID: PMC2835390          DOI: 10.1089/aid.2009.0068

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  94 in total

Review 1.  Blood-brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into the mechanism.

Authors:  Pasquale Annunziata
Journal:  J Neurol       Date:  2003-08       Impact factor: 4.849

2.  Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease.

Authors:  Marie-Chantal Simard; Pavel Chrobak; Denis G Kay; Zaher Hanna; Serge Jothy; Paul Jolicoeur
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Exogenous Nef protein activates NF-kappa B, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells. Role in AIDS pathogenesis.

Authors:  Audrey Varin; Sunil K Manna; Vincent Quivy; Anne-Zélie Decrion; Carine Van Lint; Georges Herbein; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2002-11-04       Impact factor: 5.157

4.  The protein-tyrosine phosphatase CD45 reaches the cell surface via golgi-dependent and -independent pathways.

Authors:  Troy A Baldwin; Hanne L Ostergaard
Journal:  J Biol Chem       Date:  2002-10-16       Impact factor: 5.157

5.  The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck.

Authors:  Z Hanna; X Weng; D G Kay; J Poudrier; C Lowell; P Jolicoeur
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors.

Authors:  M Federico; Z Percario; E Olivetta; G Fiorucci; C Muratori; A Micheli; G Romeo; E Affabris
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

7.  In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells.

Authors:  Andreas Jekle; Oliver T Keppler; Erik De Clercq; Dominique Schols; Mark Weinstein; Mark A Goldsmith
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

8.  Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.

Authors:  Moraima Guadalupe; Elizabeth Reay; Sumathi Sankaran; Thomas Prindiville; Jason Flamm; Andrew McNeil; Satya Dandekar
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Cardiac disease in transgenic mice expressing human immunodeficiency virus-1 nef in cells of the immune system.

Authors:  Denis G Kay; Ping Yue; Zaher Hanna; Serge Jothy; Etienne Tremblay; Paul Jolicoeur
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

10.  Human immunodeficiency virus type 1 (HIV-1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: involvement of Nef domains interacting with the cell endocytotic machinery.

Authors:  Zulema Percario; Eleonora Olivetta; Gianna Fiorucci; Giorgio Mangino; Silvia Peretti; Giovanna Romeo; Elisabetta Affabris; Maurizio Federico
Journal:  J Leukoc Biol       Date:  2003-07-22       Impact factor: 4.962

View more
  60 in total

Review 1.  Microvesicles and viral infection.

Authors:  David G Meckes; Nancy Raab-Traub
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

2.  Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling.

Authors:  Patrick E Campbell; Olexandr Isayev; Syed A Ali; William W Roth; Ming-Bo Huang; Michael D Powell; Jerzy Leszczynski; Vincent C Bond
Journal:  J Mol Model       Date:  2012-05-30       Impact factor: 1.810

3.  Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce Aβ(1-42) secretion in SH-SY5Y neural cells.

Authors:  Mahfuz B Khan; Michelle J Lang; Ming-Bo Huang; Andrea Raymond; Vincent C Bond; Bruce Shiramizu; Michael D Powell
Journal:  J Neurovirol       Date:  2015-09-25       Impact factor: 2.643

4.  Expression of a protein phosphatase 1 inhibitor, cdNIPP1, increases CDK9 threonine 186 phosphorylation and inhibits HIV-1 transcription.

Authors:  Tatiana Ammosova; Venkat R K Yedavalli; Xiaomei Niu; Marina Jerebtsova; Aleyde Van Eynde; Monique Beullens; Mathieu Bollen; Kuan-Teh Jeang; Sergei Nekhai
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

5.  Peptide-based identification of functional motifs and their binding partners.

Authors:  Martin N Shelton; Ming Bo Huang; Syed Ali; Kateena Johnson; William Roth; Michael Powell; Vincent Bond
Journal:  J Vis Exp       Date:  2013-06-30       Impact factor: 1.355

Review 6.  Role of Exosomes in Human Retroviral Mediated Disorders.

Authors:  Monique Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2018-04-14       Impact factor: 4.147

7.  Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Authors:  Martin N Shelton; Ming-Bo Huang; Syed A Ali; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

8.  Association of Cytokines With Exosomes in the Plasma of HIV-1-Seropositive Individuals.

Authors:  Kateena Addae Konadu; Jane Chu; Ming Bo Huang; Praveen Kumar Amancha; Wendy Armstrong; Michael D Powell; Francois Villinger; Vincent C Bond
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

9.  Proceedings of the 2017 ISEV symposium on "HIV, NeuroHIV, drug abuse, & EVs".

Authors:  Guoku Hu; Sowmya Yelamanchili; Fatah Kashanchi; Norman Haughey; Vincent C Bond; Kenneth W Witwer; Lynn Pulliam; Shilpa Buch
Journal:  J Neurovirol       Date:  2017-11-16       Impact factor: 2.643

Review 10.  Exosomes and their role in CNS viral infections.

Authors:  Gavin C Sampey; Shabana S Meyering; Mohammad Asad Zadeh; Mohammed Saifuddin; Ramin M Hakami; Fatah Kashanchi
Journal:  J Neurovirol       Date:  2014-02-28       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.